Method for chondrocyte expansion with phenotype retention

Details Method for chondrocyte expansion with phenotype retention Method for chondrocyte expansion with phenotype retention

2007-09-25

2007-09-25

Saucier, Sandra E. (Department: 1651)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

C435S325000, C435S377000, C435S378000, C424S093700

Reexamination Certificate

active

10956971

ABSTRACT:
The present invention provides a method that maintains chondrocyte phenotype during serial expansion by culturing a population of chondrocytes in a defined serum-free culture medium containing cytokines and on a substrate that is modified by covalent attachment of hyaluronic acid. The underlying principle is to maintain native chondrocyte phenotype by growing the dissociated chondrocytes on a substrate modified by covalent attachment of hyaluronic acid to retain native chondrocyte morphology and function. Chondrocyte expanded in this manner can be used in various medical applications to repair cartilaginous tissues that have been injured by trauma or disease. This substratum provides a microenvironment that more closely mimics that of native articular cartilage, thereby promoting chondrogenesis in a predictable manner.

REFERENCES:
patent: 4356261 (1982-10-01), Kuettner
patent: 5206023 (1993-04-01), Hunziker
patent: 5326357 (1994-07-01), Kandel
patent: 5658582 (1997-08-01), Dorigatti et al.
patent: 5676964 (1997-10-01), Della Valle et al.
patent: 5716404 (1998-02-01), Vacanti et al.
patent: 5753485 (1998-05-01), Dwulet et al.
patent: 5830741 (1998-11-01), Dwulet et al.
patent: 5866165 (1999-02-01), Liu et al.
patent: 5948692 (1999-09-01), Miyauti et al.
patent: 6235316 (2001-05-01), Adkisson
patent: 6251876 (2001-06-01), Bellini et al.
patent: 6378527 (2002-04-01), Hungerford et al.
patent: 6582960 (2003-06-01), Martin et al.
patent: 6617161 (2003-09-01), Luyten et al.
patent: 6645764 (2003-11-01), Adkisson
patent: 2002/0076810 (2002-06-01), Radice et al.
patent: 2003/0215426 (2003-11-01), French et al.
patent: 2005/0036980 (2005-02-01), Chaney et al.
Girotto D et al. 2003. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 24: 3265-3275.
Adkisson et al., “In Vitro Generation of Scaffold Independent Neocartilage,” Clin. Orthopaedics and Related Res., 2001, pp. S280-S294, vol. 391S.
Benya et al., “Dedifferentiated Chondrocytes Reexpress the Differentiated Collagen Phenotype When Cultured in Agarose Gels,” Cell, 1982, pp. 215-224, vol. 30.
Cima et al., “Hepatocyte Culture on Biodegradable Polymeric Substrates,” Biotechnology and Bioengineering, 1991, pp. 145-158, vol. 38.
Cross-Linkers product literature, 2004, Rockford, Illinois, pp. 429-440.
De Bari et al., “Failure of In Vitro-Differentiated Mesenchymal Stem Cells from the Synovial Membrane to Form Ectopic Stable Cartilage in Vivo,” Arthritis & Rheumatism, 2004, pp. 142-150, vol. 50.
De Bari et al., “Human Periosteum-Derived Cells Maintain Phenotypic Stability and Chondrogenic Potential Throughout Expansion Regardless of Donor Age,” Arthritis & Rheumatism, 2001, pp. 85-95, vol. 44.
Dell'Accio et al., “Molecular Markers Predictive of the Capacity of Expanded Human Articular Chondrocytes to Form Stable Cartilage In Vivo,” Arthritis & Rheumatism, pp. 1608-1619, vol. 44.
Farndale et al., “Improved Quantitation and Discrimination of Sulphated Glycosaminoglycans by Use of Dimethylmethylene Blue,” Biochimica et Biophysica Acta, 1986, pp. 173-177, vol. 883.
Häuselmann et al., “Phenotypic Stability of Bovine Articular Chondrocytes After Long-Term Culture in Alginate Beads,” J. Cell Sci., 1994, pp. 17-27, vol. 107.
Häuselmann et al., “Adult Human Chondrocytes Cultured in Alginate Form a Matrix Similar to Native Human Articular Cartilage,” Am. J. Physiol., 1996, pp. C742-C752, vol. 271.
Hermanson, GT Bioconjugate Techniques, 1996, San Diego, Academic Press, Inc., p. 622.
Homicz et al., “Effects of Serial Expansion of Septal Chondrocytes on Tissue-Engineered Neocartilage Composition,” Otolaryngol. Head Neck Surg., 2002, pp. 398-408, vol. 127.
Huang et al., “Chondrogenic Potential of Multipotential Cells from Human Adipose Tissue,” Plast. Reconstr. Surg., 2004, pp. 585-594, vol. 113.
Hunziker, “Articular Cartilage Repair: Basic Science and Clinical Progress. A Review of the Current Status and Prospects,” Osteoarthritis and Cartilage, 2001, pp. 432-463, vol. 10.
Jakob et al, Specific Growth Factors During the Expansion and Redifferentiation of Adult Human Articular Chondrocytes Enhance Chondrogenesis and Cartilaginous Tissue Formation in Vitro, J. Cell. Biochem., 2001, pp. 368-377, vol. 81.
Kavalkovich et al., “Chondrogenic Differentiation of Human Mesenchymal Stem Cells Within an Alginate Layer Culture System,” In Vitro Cell Dev. Biol.—Animal, 2002, pp. 457-466, vol. 38.
Kögler et al., “A New Human Somatic Stem Cell form Placental Cord Blood with Intrinsic Pluripotent Differentiation Potential,” J. Exp. Med., 2004, pp. 123-135, vol. 200.
Kujawa et al., “Hyaluronic Acid Bonded to Cell Culture Surfaces Inhibits the Program of Myogenesis,” Developmental Biol., 1986 pp. 10-16, vol. 113
Kujawa et al., “Substrate-Bonded Hyaluronic Acid Exhibits a Size-Dependent Stimulation of Chondrogenic Differentiation of Stage 24 Limb Mesenchymal Cells in Culture,” Development Biol., 1986, pp. 519-528, vol. 114.
Kujawa et al., “Hyaluronic Acid Bonded to Cell-Culture Surfaces Stimulated Chondrogenesis in Stage 24 Limb Mesenchyme Cell Cultures,” Developmental Biol., 1986, pp. 504-518, vol. 114.
Laurent et al., “Hyaluronan,” FASEB J., 1992, pp. 2397-2404, vol. 6.
Laurent, “Structure of Hyaluronic Acid,” in the Chemistry and Molecular Biology of the Intercellular Matrix, 1970, (Balazs ed., Academic Press, New York), pp. 703-732, vol. 2.
Liu et al., “An Osteoconductive Collagen/Hyaluronate Matrix for Bone Regeneration,” Biomaterials, 1999, pp. 1097-1108, vol. 20.
Mackay et al., “Chondrogenic Differentiation of Cultured Human Mesenchymal Stem Cells from Marrow,” Tissue Engineering, 1998, pp. 415-428, vol. 4.
Malpeli et al., “Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte Through Maintenance of Sox9 Expression,” Tissue Engineering, 2004, pp. 145-155, vol. 10.
Mandl et al., “Serum-Free Medium Supplemented with High-Concentration FGF2 for Cell Expansion-Culture of Human Ear Chondrocytes Promotes Redifferentiation Capacity,” Tissue Engineering, 2002, pp. 573-580, vol. 8.
Mandl et al., “Multiplication of Human Chondrocytes with Low Seeding Densities Accelerates Cell Yield Without Losing Redifferentiation Capacity,” Tissue Engineering, 2004, pp. 109-118, vol. 10.
Ornitz et al., “Fibroblast Growth Factors,” Genome Biol., 2001, pp. 1-12, vol. 2.
Ornitz, “FGFs, Heparan Sulfate and FGFRs: Complex Interactions Essential for Development,” BioEssays, 2000, pp. 108-112, vol. 22.
Osman et al., “Combined Transgenic Expression of a α-Galactosidase and α1,2-Fucosyltransferase Leads to Optimal Reduction in the Major Xenoepitope Galα(1,3)Gal,” Proc. Natl. Acad. Sci. USA, 1997, pp. 14677-14682, vol. 94.
Plotnikov et al., “Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity,” Cell, 2000, pp. 413-424, vol. 101.
Reginato et al., “Formation of Nodular Structures Resembling Mature Articular Cartilage in Long-Term Primary Cultures of Human Fetal Epiphyseal Chondrocytes on a Hydrogel Substrate,” Arthritis & Rheumatism, 1994, pp. 1338-1349, vol. 37.
Sandrin et al., “Enzymatic Remodelling of the Carbohydrate Surface of a Xenogenic Cell Substantially Reduces Human Antibody Binding and Complement-Mediated Cytolysis,” Nature medicine, 1995, pp. 1261-1267, vol. 1.
Sekiya et al., “Dexamethasone Enhances SOX9 Expression in Chondrocytes,” J. Endocrinol., 2001, pp. 573-579, vol. 169.
Singley et al., “The Spatial Distribution of Hyaluronic Acid and Mesenchymal Condensation in the Embryonic Chick Wing,” Dev. Biol., 1981, pp. 102-120, vol. 84.
Stegemann et al., ȁ

Affiliated with

Also associated with

Rating

Method for chondrocyte expansion with phenotype retention does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for chondrocyte expansion with phenotype retention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for chondrocyte expansion with phenotype retention will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3797012